294 related articles for article (PubMed ID: 34353323)
1. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
[TBL] [Abstract][Full Text] [Related]
2. Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods.
Perri M; Guta A; Kaminski N; Bonn M; Kolla G; Bayoumi A; Challacombe L; Touesnard N; Gagnon M; McDougall P; Strike C
Int J Drug Policy; 2023 Jan; 111():103905. PubMed ID: 36379109
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
4. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
[TBL] [Abstract][Full Text] [Related]
5. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
6. Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study.
Ali F; Russell C; Kaura A; Leslie P; Bayoumi AM; Hopkins S; Wells S
PLoS One; 2023; 18(10):e0292862. PubMed ID: 37844109
[TBL] [Abstract][Full Text] [Related]
7. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
8. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
9. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
[TBL] [Abstract][Full Text] [Related]
10. Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).
Viste D; Rioux W; Cristall N; Orr T; Taplay P; Morris-Miller L; Ghosh SM
BMC Public Health; 2023 Sep; 23(1):1869. PubMed ID: 37752527
[TBL] [Abstract][Full Text] [Related]
11. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
[TBL] [Abstract][Full Text] [Related]
12. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
; Austin T; Boyd J
Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
[TBL] [Abstract][Full Text] [Related]
13. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
[TBL] [Abstract][Full Text] [Related]
14. Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study.
Marshall T; Viste D; Jones S; Kim J; Lee A; Jafri F; Krieg O; Ghosh SM
Harm Reduct J; 2023 Jun; 20(1):80. PubMed ID: 37355610
[TBL] [Abstract][Full Text] [Related]
15. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
16. 'More of the same, but worse than before': A qualitative study of the challenges encountered by people who use drugs in Nova Scotia, Canada during COVID-19.
Comeau E; Bonn M; Wildeman S; Herder M
PLoS One; 2023; 18(4):e0283979. PubMed ID: 37018353
[TBL] [Abstract][Full Text] [Related]
17. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
[TBL] [Abstract][Full Text] [Related]
18. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
Kolla G; Strike C
Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
[TBL] [Abstract][Full Text] [Related]
19. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
[TBL] [Abstract][Full Text] [Related]
20. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
